These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 26159851)
1. Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients. Seo AN; Park KU; Choe G; Kim WH; Kim DW; Kang SB; Lee HS Tumour Biol; 2015 Dec; 36(12):9813-21. PubMed ID: 26159851 [TBL] [Abstract][Full Text] [Related]
2. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer. Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer. Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718 [TBL] [Abstract][Full Text] [Related]
4. The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer. Al-Saad S; Richardsen E; Kilvaer TK; Donnem T; Andersen S; Khanehkenari M; Bremnes RM; Busund LT PLoS One; 2017; 12(7):e0181527. PubMed ID: 28742836 [TBL] [Abstract][Full Text] [Related]
5. MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer. Yin W; Cheng J; Tang Z; Toruner G; Hu S; Guo M; Robinson M; Medeiros LJ; Tang G Clin Lung Cancer; 2021 Jul; 22(4):e512-e518. PubMed ID: 33288441 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation. Kwak Y; Nam SK; Seo AN; Kim DW; Kang SB; Kim WH; Lee HS Pathobiology; 2015; 82(2):76-83. PubMed ID: 26088290 [TBL] [Abstract][Full Text] [Related]
7. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma. Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108 [TBL] [Abstract][Full Text] [Related]
8. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas. Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721 [TBL] [Abstract][Full Text] [Related]
9. MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases. Ma S; Fan L; Liu Y; Wang Y; Yu K; Wang L; Fang N; Liu F; Guo S; Wang Z Diagn Pathol; 2018 Aug; 13(1):56. PubMed ID: 30126419 [TBL] [Abstract][Full Text] [Related]
10. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases. Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411 [TBL] [Abstract][Full Text] [Related]
11. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer. Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422 [TBL] [Abstract][Full Text] [Related]
12. Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis. Noonan SA; Berry L; Lu X; Gao D; Barón AE; Chesnut P; Sheren J; Aisner DL; Merrick D; Doebele RC; Varella-Garcia M; Camidge DR J Thorac Oncol; 2016 Aug; 11(8):1293-1304. PubMed ID: 27262212 [TBL] [Abstract][Full Text] [Related]
13. Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients. Lee KS; Nam SK; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS Sci Rep; 2019 Feb; 9(1):1611. PubMed ID: 30733532 [TBL] [Abstract][Full Text] [Related]
14. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method. Higaki E; Kuwata T; Nagatsuma AK; Nishida Y; Kinoshita T; Aizawa M; Nitta H; Nagino M; Ochiai A Gastric Cancer; 2016 Jan; 19(1):63-73. PubMed ID: 25487305 [TBL] [Abstract][Full Text] [Related]
15. Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma. Brauswetter D; Dános K; Gurbi B; Félegyházi ÉF; Birtalan E; Meggyesházi N; Krenács T; Tamás L; Peták I Virchows Arch; 2016 May; 468(5):579-87. PubMed ID: 26832731 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab. Sartore-Bianchi A; Moroni M; Veronese S; Carnaghi C; Bajetta E; Luppi G; Sobrero A; Barone C; Cascinu S; Colucci G; Cortesi E; Nichelatti M; Gambacorta M; Siena S J Clin Oncol; 2007 Aug; 25(22):3238-45. PubMed ID: 17664472 [TBL] [Abstract][Full Text] [Related]
17. Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization. Choi J; Lee HE; Kim MA; Jang BG; Lee HS; Kim WH PLoS One; 2014; 9(11):e111658. PubMed ID: 25364819 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures. Guo B; Cen H; Tan X; Liu W; Ke Q PLoS One; 2014; 9(6):e99399. PubMed ID: 24922520 [TBL] [Abstract][Full Text] [Related]
19. Response to Crizotinib Observed in Lung Adenocarcinoma with MET Copy Number Gain but without a High-Level MET/CEP7 Ratio, MET Overexpression, or Exon 14 Splicing Mutations. Zhang Y; Wang W; Wang Y; Xu Y; Tian Y; Huang M; Lu Y J Thorac Oncol; 2016 May; 11(5):e59-e62. PubMed ID: 26724472 [TBL] [Abstract][Full Text] [Related]
20. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers. Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]